Amy Goodale
- Aging top 10%
-
- CRISPR and Genetic Engineering 5
- Protein Degradation and Inhibitors 3
- Melanoma and MAPK Pathways 3
- RNA and protein synthesis mechanisms 3
- Advanced biosensing and bioanalysis techniques 2
- vaccines and immunoinformatics approaches 2
-
- Cancer Genomics and Diagnostics 2
-
- Acute Myeloid Leukemia Research 2
- Co-authors
- Federica PiccioniDavid E. RootJohn G. DoenchMudra HegdeKatherine DonovanChristine StrandKendall R SansonRuth E. Hanna
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Amy Goodale
15 papers receiving 855 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Aging 33
- Molecular Biology 664
- Cancer Research 109
- Business and International Management 14
- Oncology 159
Countries citing papers authored by Amy Goodale
This map shows the geographic impact of Amy Goodale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Goodale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Goodale more than expected).
Fields of papers citing papers by Amy Goodale
This network shows the impact of papers produced by Amy Goodale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Goodale. The network helps show where Amy Goodale may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amy Goodale, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 17 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 8 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2019 | 30 | |
| 10 | 2019 | 26 | |
| 11 | 2019 | 99 | |
| 12 | 2019 | 13 | |
| 13 | 2018 | 62 | |
| 14 | Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalitiesbreakdown → | 2018 | 505 |
| 15 | 2018 | 1 | |
| 16 | 2017 | 75 |
About Amy Goodale
Amy Goodale is a scholar working on Cancer Research, Hematology, Biophysics, Molecular Biology and Clinical Biochemistry, having authored 16 papers that have together received 861 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (5 papers), Protein Degradation and Inhibitors (3 papers), Melanoma and MAPK Pathways (3 papers), RNA and protein synthesis mechanisms (3 papers), Acute Myeloid Leukemia Research (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), vaccines and immunoinformatics approaches (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Aging (33 citations), Molecular Biology (664 citations), Cancer Research (109 citations), Business and International Management (14 citations) and Oncology (159 citations). Amy Goodale has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Federica Piccioni, David E. Root, John G. Doench, Mudra Hegde, Katherine Donovan, Christine Strand, Kendall R Sanson, Ruth E. Hanna, Meagan E. Sullender and Emma W Vaimberg. Their work appears in journals such as Cell Genomics, Nature Communications, Neuro-Oncology, Cancer Research and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.